Comparing two surgical techniques for testicular cancer treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the differences in patient-reported postoperative outcomes between two surgical techniques for radical orchiectomy in patients with suspected testicular cancer. It aims to determine if sparing the external oblique fascia during surgery reduces postoperative pain, narcotic consumption, neuropathic pain, and complications compared to the standard inguinal orchiectomy. The study involves participants undergoing the procedure in an outpatient setting and focuses on improving pain management and reducing opioid use post-surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants undergoing radical orchiectomy for suspected testicular malignancy
* Testicular malignancy can be germ cell tumor or non germ cell tumors, including paratesticular tumors as long as a radical orchiectomy is planned
* Participants over 18 years of age who can provide informed consent
* Participants not currently using opiates for another reason
* Regional and metastatic patients are allowed, as long as participant does not require opiates for pain related to metastatic disease
* No contraindication for participant to receive standardized medication pathway in the peri-operative period.

Exclusion Criteria:

* Clinical T4 disease
* History of illicit substance abuse (including prior opioid abuse) except for marijuana
* Participants who underwent chemotherapy or radiotherapy prior to orchiectomy
* Opioid use within 1 month of study enrollment
* Participants with large testis masses requiring skin incision larger than 8 cm in size.
* Participants with large testis masses requiring orchiectomy through an incision other than the standard transverse inguinal incision (i.e. hockey stick incision, vertical incision)

Where it's running

• Loma Linda University
  Loma Linda, California, United States Recruiting
• University of Southern California
  Los Angeles, California, United States Recruiting

Study contacts

• Study coordinator: Muhannad Alsyouf, MD
• Email: Malsyouf@llu.edu
• Phone: 9095584000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Primary retroperitoneal lymph node surgery versus chemotherapy for good‑prognosis metastatic testicular cancer

  This study will test whether primary RPLND (surgery) instead of standard chemotherapy leads to fewer side effects and better quality of life for men 18 and older with good‑prognosis metastatic testicular cancer.

  Recruiting Sahlgrenska University Hospital · Gothenburg, Göteborg · NCT07498959

• Sodium thiosulfate to protect hearing during cisplatin therapy in adults with solid tumors

  This study tests Pedmark sodium thiosulfate to see if it reduces hearing loss in adults receiving standard cisplatin chemotherapy.

  Recruiting Phase 1/2 University of Arizona · Tucson, Arizona · NCT07407582

• Navigation program for young cancer survivors

  This project tests an adapted navigation program to help adolescent and young adult cancer survivors get timely care within Kaiser Permanente Southern California.

  Recruiting Kaiser Permanente · Pasadena, California · NCT07406087

• Testing trastuzumab deruxtecan (T‑DxD) for HER2‑positive advanced solid tumors

  This will test whether trastuzumab deruxtecan (T‑DxD) helps adults in the US with HER2‑positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have had prior systemic treatment and have no satisfactory alternative options.

  Recruiting at 18 sites AstraZeneca · Birmingham, Alabama and 17 other locations · NCT07124000

• Testing GV20-0251 for advanced or treatment‑resistant solid tumors

  This study will test whether GV20-0251 is safe and tolerable when given every three weeks to adults with advanced or treatment‑resistant solid tumors such as liver, lung, pancreatic cancer, and melanoma.

  Recruiting Phase 1 West China Hospital · Chengdu, Sichuan · NCT07106827

• How retroperitoneal lymph node dissection affects urination and sexual function

  This project will see if retroperitoneal lymph node dissection (RPLND) for testicular cancer changes urination, ejaculation, erections, and quality of life in adult men.

  Recruiting Jagiellonian University · Krakow, Malopolska · NCT06954233

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.